Last checked at 13 Apr 2015 07:00
13th April 2015
Eco Animal Health Group plc (the "Company")
Trading statement
ECO Animal Health Group plc, the international producer of animal health pharmaceuticals, is pleased to release a trading statement for the year ended 31 March 2015.
The Group has continued to make strong sales progress from its more recently licensed drug registrations and by developing newly accessed markets with existing licences. Sales in sterling have grown by more than 20% over last year. As a result, the Group is likely to exceed market profit expectations for the year to 31 March 2015. The balance sheet remains strong with net cash balances of over £17m at the year end.
The interim dividend of 1.75p per share net was paid on 7th April.
The announcement of the full results for the year to 31 March 2015 will be made towards the beginning of July.
Contact:
| Peter Lawrence | 0208 336 6190 | ECO Animal Health Group plc | |||
| Marc Loomes | 0208 447 6906 | ........................”........................... | |||
| Anthony Spiro | 0208 336 6196 | Spiro Financial |
| Peel Hunt LLP (Nominated Adviser) | |||
| Dan Webster, Richard Brown, George Sellar | 020 7418 8900 |
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
Copyright Business Wire 2015